CollPlant Biotechnologies (CLGN) EBT Margin (2017 - 2025)
Historic EBT Margin for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to 4554.55%.
- CollPlant Biotechnologies' EBT Margin rose 1089954500.0% to 4554.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 107.27%, marking a year-over-year increase of 273400.0%. This contributed to the annual value of 3206.41% for FY2024, which is 31450500.0% down from last year.
- According to the latest figures from Q3 2025, CollPlant Biotechnologies' EBT Margin is 4554.55%, which was up 1089954500.0% from 1775.42% recorded in Q2 2025.
- In the past 5 years, CollPlant Biotechnologies' EBT Margin ranged from a high of 51361.43% in Q3 2021 and a low of 113550.0% during Q3 2024
- Moreover, its 5-year median value for EBT Margin was 215.85% (2021), whereas its average is 7941.04%.
- In the last 5 years, CollPlant Biotechnologies' EBT Margin tumbled by 2000000000bps in 2021 and then soared by 1089954500bps in 2025.
- CollPlant Biotechnologies' EBT Margin (Quarter) stood at 62124.19% in 2021, then skyrocketed by 87bps to 8062.07% in 2022, then soared by 79bps to 1694.98% in 2023, then crashed by -43bps to 2423.17% in 2024, then tumbled by -88bps to 4554.55% in 2025.
- Its EBT Margin was 4554.55% in Q3 2025, compared to 1775.42% in Q2 2025 and 80.19% in Q1 2025.